Viewing Study NCT06947460


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-26 @ 3:05 AM
Study NCT ID: NCT06947460
Status: RECRUITING
Last Update Posted: 2025-05-13
First Post: 2025-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
Sponsor: Beijing GoBroad Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module